Alkermes Medicines & Focus: Serious Mental Illness

This National Minority Health Month, we’re learning more about the disproportionate prevalence of mental illness, socioeconomic disparities & barriers to care in minority communities.

This April, we're talking about Mental Health Missions and making mental health a priority.

Today we observe World Bipolar Day to help lift the ~2.8% of American adults living with #bipolar disorder & coping with extreme highs & lows in mood & energy.

Dr. Rakesh Jain and Dr. Andrew Cutler guest hosted the Alkermes-sponsored MDEdge Psychiatry podcast to discuss the management of comorbidities & behavioral risk factors that may be present in people living with schizophrenia.

Early identification of a serious mental illness and intervention can be critical to disease management and improved long-term outcomes for individuals.

It's Brain Awareness Week! Raising awareness & advocating for research funding is crucial to improving the lives of people with schizophrenia & bipolar disorder.

We continue to recognize our passionate employees by spotlighting their “Why” for joining the Alkermes psychiatry team. Damon Harrell, VP of Marketing, shares why he’s inspired to make a difference for those living with serious mental illness.

Meet Jessica Tamborski -- an Alkermes employee inspired by her daughter’s struggle with bipolar disorder who is proud to work at an organization that helps people living with serious mental illness.

Psychiatrist Dr. Frank Chen sat down with PsychCentral.com’s Gabe Howard to discuss the benefits of telepsych and why it doesn’t need to be so intimidating.

Schizophrenia is a serious brain disorder affecting about 2.4 million adults in the United States. But exactly how does this disease affect certain parts of the brain?